B707 -BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
Ausschreibungsinformationen
TED EULisboa, Portugal
- Art
- 29
- Verfahren
- restricted
- Referenznummer
- 428511-2026
- Geschätzter Wert
- 83,261 EUR
- CPV
- 33600000
BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]
Lisboa, Portugal
BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]